Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)

Clinical trial NCT02338011 · UNKNOWN

Trial details

NCT number: NCT02338011
Sponsor: Shanghai Chest Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Brain Metastases EGFR Gene Mutation

Start date: 2014-11-01
Primary completion: 2017-11-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.